Ownership Summary
According to SEC filings for the period ending December 2025, bioAffinity Technologies, Inc. (NASDAQ:BIAF) is held by 4 institutional firms.
- The collective stake of institutional investors in bioAffinity Technologies moved to 5.5% in December 2025, a shift down from the 42.9% reported for September 2025.
- On a quarter-over-quarter basis, institutional holdings shifted by 4180.90%, with a year-over-year a decrease of 76.47% in the count of filers.
- A review of institutional activity for bioAffinity Technologies shows 2 of 4 filers increasing their positions, while 0 reduced their stake, and 2 remained unchanged.
- The aggregate institutional position in bioAffinity Technologies now stands at 39.00K shares as of December 2025, after investors increased their holdings (up by 38.09K shares quarter on quarter which is up 21.15K shares year over year).
- GEODE CAPITAL MANAGEMENT, LLC continues to be the largest institutional holder of bioAffinity Technologies as of December 31, 2025, with a position of 30.42K shares, representing 4.32% of the company's outstanding stock.
- Among the most significant buyers of bioAffinity Technologies during December 2025 were GEODE CAPITAL MANAGEMENT, LLC (30.42K), CITIGROUP INC (7.67K).
- The top 4 institutional holders of bioAffinity Technologies for the quarter ending December 2025 included GEODE CAPITAL MANAGEMENT, LLC (30.42K), CITIGROUP INC (7.74K), IFP Advisors, Inc (833), MORGAN STANLEY (3).